Psychiatric and neurodegenerative disorders are amongst the most prevalent and
debilitating diseases, but current treatments either have low success rates, greatly due to the …

Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

The biggest obstacle to the treatment of diseases that affect the central nervous system
(CNS) is the passage of drugs across the blood-brain barrier (BBB), a physical barrier that …

With the increment of the aging population in recent years, neurodegenerative diseases
exert a major global disease burden, essentially as a result of the lack of treatments that stop …

Disorders of the central nervous system (CNS) and tumors of the brain are challenging to
treat, and they rank amongst the most common causes of death worldwide. The delivery of …

In the last decade, the onset of neurodegenerative (ND) diseases is strongly widespread
due to the age increase of the world population. Despite the intensive investigations boosted …

Alzheimer's disease is a neurodegenerative condition leading to atrophy of the brain and
robbing nearly 5.8 million individuals in the United States age 65 and older of their cognitive …

The function of the brain can be affected by various factors that include infection, tumor, and
stroke. The major disorders reported with altered brain function are Alzheimer's disease …

Neurodegenerative diseases (NDs) such as Alzheimer's disease (AD) and Parkinson's
disease (PD) are an accelerating global health problem as life expectancy rises worldwide …

Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease,
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …